Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel SR vs IR Switching Study in Schizophrenia
NCT00206128Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2004
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Nov 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00206128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206128.